Clinical and Experimental Reproductive Medicine (CERM) is a premier journal dedicated to advancing the field of reproductive medicine. Published by the Korean Society of Reproductive Medicine, it aims to disseminate high-quality research and innovative clinical practices in reproductive health and medicine. With its Q3 ranking in reproductive medicine for 2023, CERM is positioned as a significant resource for researchers and practitioners seeking to stay current with the latest developments and findings in the field. Since its inception in 2011, CERM has provided a vital platform for original research articles, review papers, and case studies that cover a range of topics, including fertility treatments, reproductive endocrinology, and embryology. Researchers benefit from its accessibility, inspiring new insights and evidence-based approaches to clinical practices. Based in South Korea, its rigorous peer-reviewed publication process ensures that all contributions meet high academic standards, making it an invaluable asset for anyone engaged in reproductive health research or practice.

REPRODUCTION IN DOMESTIC ANIMALS is a distinguished peer-reviewed journal published by Wiley that has been at the forefront of advancing knowledge in the field of animal science since its inception in 1966. With an ISSN of 0936-6768 and an E-ISSN of 1439-0531, this journal specializes in the intricate aspects of reproductive biology in domestic species, supporting both scientific research and practical applications in agriculture. Ranked Q2 in Animal Science and Zoology and Q3 in both Biotechnology and Endocrinology, the journal plays a crucial role in addressing contemporary challenges in animal reproduction, contributing significant insights to researchers, professionals, and students alike. Although it does not currently offer open access, its editorial team is committed to publishing high-quality studies that enhance our understanding of reproductive mechanisms and foster advancements in the field. The convergence of data, innovative methodologies, and practical implications in the journal fosters a rich dialogue among scientists and practitioners worldwide, making it an essential resource for anyone invested in animal reproductive health.

The International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.

MOLECULAR HUMAN REPRODUCTION, published by Oxford University Press, is a pivotal journal dedicated to advancing the field of reproductive biology. Since its inception in 1995, the journal has been recognized for its rigorous peer-reviewed research and substantial contributions to the understanding of molecular mechanisms underlying human reproduction. With an impressive impact factor and ranked within the top tiers (Q1 and Q2) across diverse categories including Embryology, Obstetrics and Gynecology, and Reproductive Medicine, it stands as an essential resource for researchers, healthcare professionals, and students alike. The journal aims to publish cutting-edge research that explores the complexities of human reproduction at the molecular and cellular levels, fostering a deeper understanding that can be translated into clinical practice. Although it currently operates under a subscription model, the valuable insights and groundbreaking findings featured within its pages continue to influence the trajectory of reproductive health research globally. Located in the heart of Oxford, United Kingdom, the journal remains committed to addressing vital challenges in the field and promoting innovative scientific dialogue.

MOLECULAR REPRODUCTION AND DEVELOPMENT is a prestigious peer-reviewed journal published by WILEY, specializing in the intricate domains of Cell Biology, Developmental Biology, and Genetics. Since its inception in 1988, this journal has been a vital platform for disseminating pioneering research and innovative methodologies that advance our understanding of molecular mechanisms driving reproduction and development. With a current impact factor reflective of its significance in the field, MOLECULAR REPRODUCTION AND DEVELOPMENT is ranked Q3 in both Cell Biology and Developmental Biology, and Q2 in Genetics, underscoring its relevance and scholarly contribution. Catering to a diverse audience of researchers, professionals, and students, this journal not only showcases cutting-edge findings but also aims to foster interdisciplinary exchanges that enhance scientific collaboration. By exploring critical biological processes, it ultimately contributes to the broader understanding of health and disease in various organisms, making it an essential resource for anyone dedicated to the life sciences.

Reproductive Medicine is an esteemed open-access journal published by MDPI, focusing on the latest research and advances in reproductive health, fertility, and assisted reproductive technologies. With its E-ISSN of 2673-3897, the journal aims to provide a platform for researchers, clinicians, and healthcare professionals to disseminate their findings, share innovative practices, and engage in scholarly discourse. Situated in Basel, Switzerland, Reproductive Medicine emphasizes a multidisciplinary approach, exploring biological, clinical, and psychological aspects of reproductive health. Although the journal is in the early stages of establishing metrics such as H-index and Scopus rankings, its open-access model enhances accessibility, allowing for a broad dissemination of knowledge. Committed to fostering advancements in the field, Reproductive Medicine is essential for those seeking to stay at the forefront of reproductive health research.

HUMAN REPRODUCTION UPDATE, published by Oxford University Press, stands as a leading journal in the fields of Obstetrics and Gynecology and Reproductive Medicine. With an impressive Q1 ranking in both categories according to the 2023 category quartiles and a significant Scopus rank, it is recognized as one of the top journals globally in these disciplines, catering to the most relevant and cutting-edge research. The journal has been a crucial platform for disseminating vital findings and reviews from 1995 to 2024, contributing to advancements in human reproductive health. With its focus on publishing high-quality, peer-reviewed articles, it serves as an essential resource for researchers, healthcare professionals, and students seeking the latest insights and developments in reproductive science. As the journal aims to foster informed discussions and encourage further research, it remains committed to shaping the future of reproductive health and medicine.

Reproduction and Fertility is a premier academic journal published by BIOSCIENTIFICA LTD, dedicated to advancing knowledge in the fields of reproductive sciences, obstetrics, gynecology, and related areas. Established with a focus on delivering high-quality research, this journal has quickly ascended in prominence, achieving a commendable Q2 ranking in multiple categories, including Embryology, Obstetrics and Gynecology, Reproductive Medicine, and Urology, as of 2023. With an E-ISSN of 2633-8386, Reproduction and Fertility aims to provide a valuable platform for researchers, professionals, and students alike, offering insights into the latest discoveries and innovations in reproductive health. Although currently not an open-access journal, it remains committed to disseminating important findings that can influence clinical practices and policy-making worldwide. Operating from its headquarters in Bristol, United Kingdom, the journal serves as an essential resource for anyone invested in understanding and improving reproductive health outcomes through rigorous academic research.

Reproductive Biology and Endocrinology, published by BMC, is a distinguished open-access journal established in 2003, catering to researchers and professionals in the interdisciplinary fields of reproductive biology, endocrinology, and related biomedical sciences. With a notable impact in 2023, the journal has achieved Q1 rankings in Obstetrics and Gynecology, Reproductive Medicine, and Endocrinology, alongside a Q2 ranking in Developmental Biology, establishing itself as a pivotal source of high-quality research and insights. The journal's commitment to freely accessible research promotes knowledge dissemination across its domains, which is crucial for advancing understanding of reproductive health and endocrine mechanisms. With a robust Scopus ranking showcasing its relevance—17th out of 209 in Obstetrics and Gynecology, and 8th out of 90 in Reproductive Medicine—it serves as an essential resource for academics and clinicians alike, facilitating innovative research and fostering collaboration within the global scientific community.

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.